Event Brief
Mar 10, 2026 at 2:10 PM ET
FDA Approves Leucovorin for Rare Cerebral Folate Deficiency
By The BriefBrief
The FDA has approved leucovorin calcium tablets for treating a rare neurological disorder, cerebral folate deficiency.
WHO: Food and Drug Administration
WHAT: Approved expanded use of leucovorin calcium tablets
WHEN: Mar 10, 2026 at 12:26 PM ET
WHERE: Location not specified
WHY: To treat cerebral folate deficiency, a rare neurological condition
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia
May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21430 of 21430
Same format. Every time.
Continue reading — sign in or create a free account with
